Search & Filter
Date Range
Resource Type
HRS Endorsed
Audience
Topic
Manufacturer
Device Type
FDA Class
Podcasts
The Lead Episode 78: A Discussion of The Potential of AI to Revolutionize Healthcare Delivery Research and Education in Cardiac EP & Understanding AI Biases in Clinical Practice (Recorded live at HRX in Atlanta)
In this episode of The Lead, brought to you live from HRX, Deepthy Varghese interviews author Sana Al-Khatib on two of her recent publications.
October 10, 2024
Podcasts
The Lead Episode 77: A Discussion of Pulmonary Vein Isolation vs Sham Intervention in Symptomatic Atrial Fibrillation (Recorded live at HRX in Atlanta)
Compare Pulmonary Vein Isolation and Sham Intervention in Symptomatic Atrial Fibrillation.
September 19, 2024
Podcasts
The Lead Episode 76: A Discussion of Asundexian versus Apixaban in Patients with Atrial Fibrillation (Recorded live at HRX in Atlanta)
Compare the use of Asundexian in patients with atrial fibrillation to the use of Apixaban in patients with atrial fibrillation.
September 12, 2024
Podcasts
The Lead Episode 75: A Discussion of Pulmonary Vein Isolation With or Without Left Atrial Appendage Ligation in Atrial Fibrillation: The aMAZE Randomized Clinical Trial
Dr. Michael S. Lloyd, MD, FHRS, Emory University is joined by Lucas V. A. Boersma, MD, PhD, St Antonius Hospital, and Michael Hoskins, MD, New…
August 22, 2024
Podcasts
The Lead Episode 74: A Discussion of Incidence and Patterns of Atrial Fibrillation After Catheter Ablation of Typical Atrial Flutter—The FLUTFIB Study
Examine the incidence, duration, timing, and symptoms of atrial fibrillation (AF) after cavotricuspid isthmus (CTI) ablation in patients with atrial flutter (AFL) through the results…
August 15, 2024
Podcasts
The Lead Episode 73: A Discussion of Time to Benefit and Harm of Direct Oral Anticoagulants in Device-Detected Atrial Fibrillation: A Pooled Analysis of the NOAH-AFNET 6 and ARTESiA Trials
To discuss the recently published manuscript, entitled, "Time to Benefit and Harm of Direct Oral Anticoagulants in Device-Detected Atrial Fibrillation: A Pooled Analysis of the…
August 8, 2024
Podcasts
The Lead Episode 72: A Discussion of The Predictive Value of PRECISE-DAPT Scores for Thrombogenic Milieu of the Left Atrium in Patients Awaiting AF Ablation
Understand the utility of the PRECISE-DAPT score in predicting thromboembolic risk in nonvalvular atrial fibrillation (AF) patients undergoing transesophageal echocardiography (TEE) prior to AF ablation.
August 1, 2024
Podcasts
The Lead Episode 71: A Discussion of Fascicular Substrate Modification to Treat Human Ventricular Fibrillation
To review and discuss the recently published manuscript entitled "Fascicular Substrate Modification to Treat Human Ventricular Fibrillation"
July 25, 2024
Podcasts
The Lead Episode 70: A Discussion of the 2024 EHRA/HRS/APHRS/LAHRS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation
Michael S. Lloyd, MD, FHRS, Emory University, is joined by Jayanthi N. Koneru, MBBS, FHRS, VCU Medical Center, Cardiology and S. Patrick Whalen, MD, FHRS, Wake Forest University, School of Medicine to…
July 18, 2024
Podcasts
The Lead Episode 69: A Discussion of Effect of Carvedilol vs Metoprolol on Atrial and Ventricular Arrhythmias Among Implantable Cardioverter-Defibrillator Recipients
Listen to Deepthy Varghese, Sirena Bridges, and Jodie L. Hurwitz discuss the effects of metoprolol and carvedilol on the risk of atrial tachyarrhythmia (ATA) and…
July 11, 2024